Postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer that has spread to a limited number of lymph nodes, and whose recurrence risk is relatively low, do not benefit from chemotherapy when it is added to hormone therapy, according to initial results from a clinical trial presented at the… Continue reading Some Breast Cancer Patients May Not Benefit from Chemotherapy
Tag: hormone therapy
Widely Used Hormone Therapy for Breast Cancer Doesn’t Cause Cognitive Decline
University of California, Los Angeles researchers have found that commonly used hormone therapies for women diagnosed with breast cancer do not appear to cause significant cognitive dysfunction following the treatment. Endocrine therapy has become an essential part of treatment for the many women diagnosed with hormone-receptor positive breast cancer, in which hormones, such as estrogen,… Continue reading Widely Used Hormone Therapy for Breast Cancer Doesn’t Cause Cognitive Decline
Hormone Therapy and Cognitive Impairment
It’s well known that hormones can affect everything that goes on in a woman’s body, from sexual libido to weight gain and overall mood. Now, though, a new study shows that in the right combination, they may also help with mild cognitive impairment (MCI) in post-menopausal women. The study was published in Menopause, the journal… Continue reading Hormone Therapy and Cognitive Impairment
Menopausal Hormone Therapy Not Associated with Mortality or Deaths from Cardiovascular Disease
The Women’s Health Initiative (WHI) hormone therapy trials tested the most common formulations of hormone therapy – estrogen and progestin, and estrogen alone – to assess the benefits and risks of menopausal hormone therapy taken for chronic disease prevention, by predominantly healthy postmenopausal women. Health outcomes have been previously reported but the earlier reports did… Continue reading Menopausal Hormone Therapy Not Associated with Mortality or Deaths from Cardiovascular Disease
Study: Breast-Cancer Patients on Opioids Less Likely to Follow Treatment Regimen
Breast cancer patients who take opioids to manage their pain are less likely to adhere to a potentially lifesaving treatment regimen, according to new research. The treatment, adjuvant endocrine therapy, commonly known as hormone therapy, is used to prevent the cancer from returning after surgery, chemotherapy or radiation therapy. Opioid use, however, was “significantly associated”… Continue reading Study: Breast-Cancer Patients on Opioids Less Likely to Follow Treatment Regimen
Why Some Women Don’t Follow Up on Breast-Cancer Therapy
Researchers have found that patients who did not adhere to their medication schedule for chronic conditions, such as diabetes, prior to a breast cancer diagnosis were twice as likely to skip oral adjuvant hormonal therapy after their diagnosis. Patients who skipped medications for their chronic conditions had a 23 percent non-adherence rate to hormone treatment,… Continue reading Why Some Women Don’t Follow Up on Breast-Cancer Therapy
Millions of Women Are Getting Unregulated Hormone-Therapy Treatments
Millions of women are being prescribed hormone therapy with mostly unregulated compounds, according to a new study. The number of prescriptions has reached an estimated 26 to 33 million a year. That approaches the 36 million prescriptions per year for well-regulated and tested FDA-approved hormone therapy, shows an analysis of the market compounded hormone therapy… Continue reading Millions of Women Are Getting Unregulated Hormone-Therapy Treatments
The Hormone Therapy Decision
The end of the “hormone therapy era” appears to have been greatly exaggerated. More than a decade ago, research from the Women’s Health Initiative, a major study, advised menopausal women to stop their hormone replacement therapy due to a reported increase in breast cancer, strokes and heart attacks. In the years since then, though, potential… Continue reading The Hormone Therapy Decision
Most Women Don’t Know Stroke Symptoms
According to a national survey by The Ohio State University, most women don’t know their risk factors for stroke, or its symptoms. Investigators from the university’s Wexner Medical Center found that among 1,000 women who were surveyed, only 11 percent could identify pregnancy, lupus, migraine headaches and oral contraception or hormone replacement therapy as female-specific… Continue reading Most Women Don’t Know Stroke Symptoms
HRT Neither Raises Nor Lowers Risk of Dying
Menopausal hormone therapy (HT) does not have a significant effect on the risk of death, according to a Mayo Clinic review of the medical literature published over the past three decades. The results, which included studies with follow-up as long as 18 years, were presented in March 2015 at the Endocrine Society’s 97th annual meeting… Continue reading HRT Neither Raises Nor Lowers Risk of Dying